Literature DB >> 21139806

Conditional PPARγ knockout from cardiomyocytes of adult mice impairs myocardial fatty acid utilization and cardiac function.

Jinwen Luo, Sijie Wu, Jian Liu, Yuquan Li, Huan Yang, Teayoun Kim, Olga Zhelyabovska, Guoliang Ding, Yiqun Zhou, Yifeng Yang, Qinglin Yang.   

Abstract

While the roles of PPARα and PPARδ (β) in transcriptional regulation of myocardial lipid metabolisms are well established, an essential role of PPARγ in regulating lipid metabolisms in the adult heart remains unclear. In this study, we investigated whether PPARγ is required for normal myocardial lipid metabolism at basal condition in adult mice. We assessed the short-term cardiomyocyte-restricted PPARγ knockout mice with a Tamoxifen inducible Cre-LoxP mediated gene targeting strategy. The expression of PPARγ mRNA and protein in cardiomyocytes of adult mice was substantially reduced after short-term induction. Transcript and protein levels of important proteins in fatty acid uptake and oxidation, such as CD36, heart type-fatty acid binding protein (FABP), and carnitine palmitoyltransferase I (CPT-I) were reduced in the PPARγ deficient hearts. Myocardial fatty acid utilization and cardiac contraction were depressed in PPARγ deficient hearts. The PPARγ deficient hearts exhibited modest cardiac hypertrophy compared with controls. These results indicate that PPARγ is a transcription factor that is required for basal myocardial fatty acid utilization in the adult heart.

Entities:  

Keywords:  PPARγ; cardiac function; fatty acid metabolism; fatty acid utilization

Year:  2010        PMID: 21139806      PMCID: PMC2981426     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  35 in total

1.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.

Authors:  I Issemann; S Green
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

2.  Retinoid X receptor alpha represses GATA-4-mediated transcription via a retinoid-dependent interaction with the cardiac-enriched repressor FOG-2.

Authors:  Martha L Clabby; Trevor A Robison; Heather F Quigley; David B Wilson; Daniel P Kelly
Journal:  J Biol Chem       Date:  2002-12-11       Impact factor: 5.157

3.  Hypoxia inhibits the peroxisome proliferator-activated receptor alpha/retinoid X receptor gene regulatory pathway in cardiac myocytes: a mechanism for O2-dependent modulation of mitochondrial fatty acid oxidation.

Authors:  J M Huss; F H Levy; D P Kelly
Journal:  J Biol Chem       Date:  2001-05-22       Impact factor: 5.157

4.  Regulation of lipoprotein lipase by the oxysterol receptors, LXRalpha and LXRbeta.

Authors:  Y Zhang; J J Repa; K Gauthier; D J Mangelsdorf
Journal:  J Biol Chem       Date:  2001-09-18       Impact factor: 5.157

5.  Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice.

Authors:  Sheng Zhong Duan; Christine Y Ivashchenko; Mark W Russell; David S Milstone; Richard M Mortensen
Journal:  Circ Res       Date:  2005-07-28       Impact factor: 17.367

6.  Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.

Authors:  K Yamamoto; R Ohki; R T Lee; U Ikeda; K Shimada
Journal:  Circulation       Date:  2001-10-02       Impact factor: 29.690

7.  Changes in expression levels of genes involved in fatty acid metabolism: upregulation of all three members of the PPAR family (alpha, gamma, delta) and the newly described adiponectin receptor 2, but not adiponectin receptor 1 during neonatal cardiac development of the rat.

Authors:  Michael Steinmetz; Thomas Quentin; Andrea Poppe; Thomas Paul; Christian Jux
Journal:  Basic Res Cardiol       Date:  2005-03-09       Impact factor: 17.165

8.  Peroxisome proliferator-activated receptor {delta} is an essential transcriptional regulator for mitochondrial protection and biogenesis in adult heart.

Authors:  Peiyong Wang; Jian Liu; Yuquan Li; Sijie Wu; Jinwen Luo; Huan Yang; Ramasamy Subbiah; John Chatham; Olga Zhelyabovska; Qinglin Yang
Journal:  Circ Res       Date:  2010-01-14       Impact factor: 17.367

9.  The peroxisome proliferator-activated receptor gamma (PPARgamma) is highly expressed in human heart ventricles.

Authors:  Mohammad R Mehrabi; Theresia Thalhammer; Petra Haslmayer; Helmut D Glogar; Georg Wieselthaler; Susanne Humpeler; Wolfgang Marktl; Cem Ekmekcioglu
Journal:  Biomed Pharmacother       Date:  2002-10       Impact factor: 6.529

10.  Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart.

Authors:  Eileen M Burkart; Nandakumar Sambandam; Xianlin Han; Richard W Gross; Michael Courtois; Carolyn M Gierasch; Kooresh Shoghi; Michael J Welch; Daniel P Kelly
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

View more
  17 in total

1.  Peroxisome-proliferator-activated receptors regulate redox signaling in the cardiovascular system.

Authors:  Teayoun Kim; Qinglin Yang
Journal:  World J Cardiol       Date:  2013-06-26

Review 2.  Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association.

Authors:  Heinrich Taegtmeyer; Martin E Young; Gary D Lopaschuk; E Dale Abel; Henri Brunengraber; Victor Darley-Usmar; Christine Des Rosiers; Robert Gerszten; Jan F Glatz; Julian L Griffin; Robert J Gropler; Hermann-Georg Holzhuetter; Jorge R Kizer; E Douglas Lewandowski; Craig R Malloy; Stefan Neubauer; Linda R Peterson; Michael A Portman; Fabio A Recchia; Jennifer E Van Eyk; Thomas J Wang
Journal:  Circ Res       Date:  2016-03-24       Impact factor: 17.367

3.  Dual transcriptional activator and repressor roles of TBX20 regulate adult cardiac structure and function.

Authors:  Noboru J Sakabe; Ivy Aneas; Tao Shen; Leila Shokri; Soo-Young Park; Martha L Bulyk; Sylvia M Evans; Marcelo A Nobrega
Journal:  Hum Mol Genet       Date:  2012-02-10       Impact factor: 6.150

4.  Exposure to rosiglitazone, a PPAR-γ agonist, in late gestation reduces the abundance of factors regulating cardiac metabolism and cardiomyocyte size in the sheep fetus.

Authors:  Shervi Lie; Melisa Hui; I Caroline McMillen; Beverly S Muhlhausler; Giuseppe S Posterino; Stacey L Dunn; Kimberley C Wang; Kimberley J Botting; Janna L Morrison
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-01-29       Impact factor: 3.619

Review 5.  Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy.

Authors:  Brahmanaidu Parim; V V Sathibabu Uddandrao; Ganapathy Saravanan
Journal:  Heart Fail Rev       Date:  2019-03       Impact factor: 4.214

6.  Regulation of peroxisome proliferator-activated receptor gamma on milk fat synthesis in dairy cow mammary epithelial cells.

Authors:  Lili Liu; Ye Lin; Lixin Liu; Lina Wang; Yanjie Bian; Xuejun Gao; Qingzhang Li
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-06-10       Impact factor: 2.416

7.  Ectopic Overexpression of PPARγ2 in the Heart Determines Differences in Hypertrophic Cardiomyopathy After Treatment With Different Thiazolidinediones in a Mouse Model of Diabetes.

Authors:  Xuemei Cao; Min Mao; Junlin Diao; Yi Hou; Hong Su; Yongjun Gan; Jibin Li; Xiaoyong Tong; Chaodong Wu; Zhong Zuo; Xiaoqiu Xiao
Journal:  Front Pharmacol       Date:  2021-07-07       Impact factor: 5.810

8.  Cardiomyocyte-Restricted Deletion of PPARβ/δ in PPARα-Null Mice Causes Impaired Mitochondrial Biogenesis and Defense, but No Further Depression of Myocardial Fatty Acid Oxidation.

Authors:  Jian Liu; Peiyong Wang; Lan He; Yuquan Li; Jinwen Luo; Lihong Cheng; Qianhong Qin; Lawrence A Brako; Woo-Kuen Lo; William Lewis; Qinglin Yang
Journal:  PPAR Res       Date:  2011-09-05       Impact factor: 4.964

Review 9.  The Glitazars Paradox: Cardiotoxicity of the Metabolically Beneficial Dual PPARα and PPARγ Activation.

Authors:  Charikleia Kalliora; Konstantinos Drosatos
Journal:  J Cardiovasc Pharmacol       Date:  2020-11       Impact factor: 3.271

10.  Effects of PPARs agonists on cardiac metabolism in littermate and cardiomyocyte-specific PPAR-γ-knockout (CM-PGKO) mice.

Authors:  Michelangela Barbieri; Clara Di Filippo; Antonietta Esposito; Raffaele Marfella; Maria Rosaria Rizzo; Michele D'Amico; Franca Ferraraccio; Cristina Di Ronza; Sheng Zhong Duan; Richard M Mortensen; Francesco Rossi; Giuseppe Paolisso
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.